WHO ICTRP trial

In vivo evaluation of the effectiveness of two antiseptic solutions in reducing…

RBR-10hj7jyn · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting

Key facts

Trial ID RBR-10hj7jyn
Public title In vivo evaluation of the effectiveness of two antiseptic solutions in reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19
Scientific title In vivo evaluation of the effectiveness of two antiseptic solutions in reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19
Primary sponsor Universidade do Estado do Rio de Janeiro
Secondary sponsors Universidade do Estado do Rio de Janeiro
Registry Registro Brasileiro de Ensaios Clinicos (ReBEC)
Recruitment status Recruiting
Study type Intervention
Phase 4
Countries Brazil
Conditions Coronavirus infection of unspecified location
Interventions Experimental Group 1: 12 individuals, with symptoms of COVID-19 and who had already tested positive for SARS-CoV-2 using nasopharyngeal swabs, they will receive a mouthwash containing: A- chlorhexidine solution (0.12%). Experimental Group…
Registration date Apr 2, 2021
Registry page ensaiosclinicos.gov.br

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations